340 related articles for article (PubMed ID: 28762264)
1. Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells.
Wang J; Li W; Zhang L; Ban L; Chen P; Du W; Feng X; Liu BF
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27441-27452. PubMed ID: 28762264
[TBL] [Abstract][Full Text] [Related]
2. Magnetic-Based Microfluidic Device for On-Chip Isolation and Detection of Tumor-Derived Exosomes.
Xu H; Liao C; Zuo P; Liu Z; Ye BC
Anal Chem; 2018 Nov; 90(22):13451-13458. PubMed ID: 30234974
[TBL] [Abstract][Full Text] [Related]
3. Cloaked Exosomes: Biocompatible, Durable, and Degradable Encapsulation.
Kumar S; Michael IJ; Park J; Granick S; Cho YK
Small; 2018 Aug; 14(34):e1802052. PubMed ID: 30024108
[TBL] [Abstract][Full Text] [Related]
4. Lipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery.
Liu C; Feng Q; Sun J
Adv Mater; 2019 Nov; 31(45):e1804788. PubMed ID: 30570773
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic device for the analysis of MDR cancerous cell-derived exosomes' response to nanotherapy.
Qi R; Zhu G; Wang Y; Wu S; Li S; Zhang D; Bu Y; Bhave G; Han R; Liu X
Biomed Microdevices; 2019 Mar; 21(2):35. PubMed ID: 30906967
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomes.
Hisey CL; Dorayappan KDP; Cohn DE; Selvendiran K; Hansford DJ
Lab Chip; 2018 Oct; 18(20):3144-3153. PubMed ID: 30191215
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.
Kanwar SS; Dunlay CJ; Simeone DM; Nagrath S
Lab Chip; 2014 Jun; 14(11):1891-900. PubMed ID: 24722878
[TBL] [Abstract][Full Text] [Related]
8. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
Xitong D; Xiaorong Z
Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
[TBL] [Abstract][Full Text] [Related]
10. Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization.
Akbari A; Nazari-Khanamiri F; Ahmadi M; Shoaran M; Rezaie J
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678695
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.
Jo W; Jeong D; Kim J; Cho S; Jang SC; Han C; Kang JY; Gho YS; Park J
Lab Chip; 2014 Apr; 14(7):1261-9. PubMed ID: 24493004
[TBL] [Abstract][Full Text] [Related]
12. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
13. Microfluidic on-demand engineering of exosomes towards cancer immunotherapy.
Zhao Z; McGill J; Gamero-Kubota P; He M
Lab Chip; 2019 May; 19(10):1877-1886. PubMed ID: 31044204
[TBL] [Abstract][Full Text] [Related]
14. A double tangential flow filtration-based microfluidic device for highly efficient separation and enrichment of exosomes.
Hua X; Zhu Q; Liu Y; Zhou S; Huang P; Li Q; Liu S
Anal Chim Acta; 2023 Jun; 1258():341160. PubMed ID: 37087290
[TBL] [Abstract][Full Text] [Related]
15. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies.
Yang F; Liao X; Tian Y; Li G
Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28166394
[TBL] [Abstract][Full Text] [Related]
16. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
[TBL] [Abstract][Full Text] [Related]
17. Exosome Purification and Analysis Using a Facile Microfluidic Hydrodynamic Trapping Device.
Tayebi M; Zhou Y; Tripathi P; Chandramohanadas R; Ai Y
Anal Chem; 2020 Aug; 92(15):10733-10742. PubMed ID: 32613828
[TBL] [Abstract][Full Text] [Related]
18. Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds.
Farooqi AA; Desai NN; Qureshi MZ; Librelotto DRN; Gasparri ML; Bishayee A; Nabavi SM; Curti V; Daglia M
Biotechnol Adv; 2018; 36(1):328-334. PubMed ID: 29248680
[TBL] [Abstract][Full Text] [Related]
19. [Construction of engineered exosomes with high loading efficiency of cellular endogenous proteins].
Huang L; Wang D; Gu N; Zhang XE
Sheng Wu Gong Cheng Xue Bao; 2019 Aug; 35(8):1537-1545. PubMed ID: 31441625
[TBL] [Abstract][Full Text] [Related]
20. Towards Microfluidic-Based Exosome Isolation and Detection for Tumor Therapy.
Wang J; Ma P; Kim DH; Liu BF; Demirci U
Nano Today; 2021 Apr; 37():. PubMed ID: 33777166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
